Shames B, Fox J G, Dewhirst F, Yan L, Shen Z, Taylor N S
Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts.
J Clin Microbiol. 1995 Nov;33(11):2968-72. doi: 10.1128/jcm.33.11.2968-2972.1995.
The identification of a new murine pathogen, Helicobacter hepaticus, and its association with chronic active hepatitis and liver tumors prompted an evaluation of the prevalence of H. hepaticus in commercially available mice. Of the 28 different strains or stocks, totaling 160 mice from four major commercial vendors, cultured for H. hepaticus, 100% of mice from two outbred strains from one vendor were infected with H. hepaticus, whereas 9 of 13 inbred mouse strains from another vendor were infected. This high prevalence of H. hepaticus established a need for a rapid and reproducible, noninvasive assay for the screening of colony-maintained mice being used for biomedical research. The culturing of fecal material by using 0.45-microns-pore- size filtration for H. hepaticus consistently yielded reproducible results but required extended periods of time. (1 to 3 weeks) to obtain a definitive answer. Although it is rapid, the use of a direct PCR-based detection assay with fecal specimens is restricted by inhibitory agents. to circumvent these inhibitory agents and to augment our H. hepaticus culture technique, we have developed a novel PCR system in which the bacteria are isolated from fecal material in the presence of polyvinylpyropyrollidone and lysed by treatment with Chelex 100. The PCR is performed with Tth polymerase supplemented with a polymerase enhancer. By this PCR method, 24 H. hepaticus culture-positive and 30 H. hepaticus culture-negative fecal samples were correctly identified. Moreover, two samples which were PCR positive and culture negative initially were positive by both methods upon retesting of fresh material. Southern blot hybridizations and sequencing of PCR products showed them to be H. hepaticus specific. A comparison of results obtained under identical conditions indicated a 100-fold increase in sensitivity with Tth polymerase over Taq polymerase. This PCR method can be used as a noninvasive means of rapidly screening large numbers of colony mice for H. hepaticus.
一种新的鼠类病原体——肝螺杆菌的发现,以及它与慢性活动性肝炎和肝肿瘤的关联,促使人们对市售小鼠中肝螺杆菌的流行情况进行评估。在来自四大商业供应商的总共160只小鼠(分属28个不同品系或种群)中培养肝螺杆菌,来自一个供应商的两个远交系小鼠100%感染了肝螺杆菌,而来自另一个供应商的13个近交系小鼠中有9只被感染。肝螺杆菌的这种高流行率表明,需要一种快速、可重复的非侵入性检测方法来筛查用于生物医学研究的种群维持小鼠。通过使用孔径为0.45微米的过滤器培养粪便材料来检测肝螺杆菌,结果始终具有可重复性,但需要较长时间(1至3周)才能得到确切结果。虽然基于直接PCR的粪便标本检测方法快速,但受抑制剂的限制。为了规避这些抑制剂并改进我们的肝螺杆菌培养技术,我们开发了一种新型PCR系统,该系统在聚乙烯吡咯烷酮存在的情况下从粪便材料中分离细菌,并用Chelex 100处理使其裂解。PCR使用补充了聚合酶增强剂的Tth聚合酶进行。通过这种PCR方法,正确鉴定了24份肝螺杆菌培养阳性和30份肝螺杆菌培养阴性的粪便样本。此外,最初PCR阳性但培养阴性的两个样本在重新检测新鲜材料时两种方法均呈阳性。Southern印迹杂交和PCR产物测序表明它们具有肝螺杆菌特异性。在相同条件下获得的结果比较表明,与Taq聚合酶相比,Tth聚合酶的灵敏度提高了100倍。这种PCR方法可作为一种非侵入性手段,快速筛查大量种群小鼠是否感染肝螺杆菌。